Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia

被引:0
|
作者
Connor Walsh
Anthony Hunter
Terra Lasho
Christy Finke
Rhett Ketterling
Rami Komrokji
Ayalew Tefferi
Abhishek Mangaonkar
Matthew Howard
Naseema Gangat
Aref Al-Kali
Najla Al Ali
Eric Padron
Mrinal M. Patnaik
机构
[1] Mayo Clinic,Alix School of Medicine
[2] Moffitt Cancer Center,Division of Hematology and Oncology
[3] Mayo Clinic,Division of Hematology, Department of Internal Medicine
[4] Mayo Clinic,Department of Laboratory Medicine and Pathology
[5] Moffitt Cancer Center,Deparmenent of Malignant Hematology
来源
Leukemia | 2022年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1693 / 1696
页数:3
相关论文
共 50 条
  • [41] IDH1 and IDH2 mutations in Bulgarian patients with glial tumours
    Goranova, T.
    Stancheva, G.
    Mitkova, A.
    Kaneva, R.
    Poptodorov, G.
    Velinov, N.
    Mitev, V.
    Gabrovsky, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 224 - 225
  • [42] IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies
    Oki, K.
    Takita, J.
    Hiwatari, M.
    Nishimura, R.
    Sanada, M.
    Okubo, J.
    Adachi, M.
    Sotomatsu, M.
    Kikuchi, A.
    Igarashi, T.
    Hayashi, Y.
    Ogawa, S.
    LEUKEMIA, 2011, 25 (02) : 382 - +
  • [43] Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
    Schaap, Frank G.
    French, Pim J.
    Bovee, Judith V. M. G.
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (01) : 32 - 38
  • [44] Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
    Haider, Ali S.
    Ene, Chibawanye I.
    Palmisciano, Paolo
    Haider, Maryam
    Rao, Ganesh
    Ballester, Leomar Y.
    Fuller, Gregory N.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] IDH1 and IDH2 hotspot mutations are not found in canine glioma
    Reitman, Zachary J.
    Olby, Natasha J.
    Mariani, Christopher L.
    Thomas, Rachael
    Breen, Matthew
    Bigner, Darell D.
    McLendon, Roger E.
    Yan, Hai
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) : 245 - 246
  • [46] Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
    Sonoda, Yukihiko
    Kumabe, Toshihiro
    Nakamura, Taigen
    Saito, Ryuta
    Kanamori, Masayuki
    Yamashita, Yoji
    Suzuki, Hiroyoshi
    Tominaga, Teiji
    CANCER SCIENCE, 2009, 100 (10) : 1996 - 1998
  • [47] Inhibitors of mutant IDH1 and IDH2
    Pamela Feliciano
    Nature Genetics, 2013, 45 (5) : 477 - 477
  • [48] Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
    Mathieu Simonin
    Aline Schmidt
    Christophe Bontoux
    Marie-Émilie Dourthe
    Etienne Lengliné
    Guillaume P. Andrieu
    Ludovic Lhermitte
    Carlos Graux
    Nathalie Grardel
    Jean-Michel Cayuela
    Françoise Huguet
    Isabelle Arnoux
    Stéphane Ducassou
    Elizabeth Macintyre
    Virginie Gandemer
    Hervé Dombret
    Arnaud Petit
    Norbert Ifrah
    André Baruchel
    Nicolas Boissel
    Vahid Asnafi
    Journal of Hematology & Oncology, 14
  • [49] INCIDENCE AND TYPE OF IDH1 AND IDH2 MUTATIONS IN AML-NK PATIENTS AND THEIR PROGNOSTIC IMPACT ON TREATMENT OUTCOME
    Kim, H. J.
    Kim, Y. K.
    Kook, H.
    Lee, I. K.
    Kim, N.
    Kim, D. D. H.
    Kim, H. J.
    Jung, C. W.
    Jang, J. H.
    Moon, J. H.
    Sohn, S. K.
    Won, J. H.
    Kim, S. H.
    Huh, J.
    Jung, S. H.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    HAEMATOLOGICA, 2014, 99 : 298 - 299
  • [50] Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
    Simonin, Mathieu
    Schmidt, Aline
    Bontoux, Christophe
    Dourthe, Marie-Emilie
    Lengline, Etienne
    Andrieu, Guillaume P.
    Lhermitte, Ludovic
    Graux, Carlos
    Grardel, Nathalie
    Cayuela, Jean-Michel
    Huguet, Francoise
    Arnoux, Isabelle
    Ducassou, Stephane
    Macintyre, Elizabeth
    Gandemer, Virginie
    Dombret, Herve
    Petit, Arnaud
    Ifrah, Norbert
    Baruchel, Andre
    Boissel, Nicolas
    Asnafi, Vahid
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)